Clinical Trial Update: Study on the Usage, Dosing, Tolerability, and Effectiveness of Kaletra Tablet

View source ↗

Summary

A completed AbbVie-sponsored trial evaluated the usage, dosing, tolerability, and effectiveness of Kaletra tablets in HIV infection. Results were posted in 2017…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kaletra Tablet (lopinavir/ritonavir)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Human Immunodeficiency Virus | Status: COMPLETED | Results posted: 2017-05-23